

Can't find Rifaximin at your pharmacy? Here are proven tools and tips to help you locate Rifaximin (Xifaxan) in stock near you in 2026.
Getting a prescription for Rifaximin (brand name Xifaxan) is only half the battle. For many patients in 2026, the bigger challenge is actually finding a pharmacy that has it in stock. Whether you take Rifaximin for hepatic encephalopathy, IBS-D, or another condition, running into "out of stock" messages is stressful — especially when you need the medication to manage serious symptoms.
The good news? Rifaximin is out there. You just need the right approach. In this guide, we'll walk you through three proven strategies to find Rifaximin in stock, plus what to do if none of them work.
If you're wondering why this medication is so hard to find in the first place, check out our explainer: Why Is Rifaximin So Hard to Find?
The fastest way to find Rifaximin near you is to use Medfinder. Instead of calling pharmacy after pharmacy, Medfinder shows you which locations currently have Rifaximin available — saving you hours of phone calls and wasted trips.
Here's how to use it:
This is especially helpful because Rifaximin is a high-cost, brand-only medication that many pharmacies don't keep in large quantities. Real-time availability data takes the guesswork out of the process.
If the big chain pharmacies near you are out of stock, don't stop there. Independent pharmacies and specialty pharmacies are often your best bet for finding Rifaximin. Here's why:
When calling, ask two questions: "Do you have Rifaximin 550 mg in stock?" and "If not, how quickly can you order it?" Most pharmacies can get it within one to two business days if their distributor has supply.
Timing matters more than you might think. Here are a few strategies:
If you've tried the strategies above and still can't locate Rifaximin, here are additional options:
Depending on your condition, your doctor may be able to prescribe a temporary alternative while you wait for Rifaximin to become available. Common alternatives include Lactulose for hepatic encephalopathy and Metronidazole for bacterial overgrowth. Read more in our article: Alternatives to Rifaximin If You Can't Fill Your Prescription.
Bausch Health (the parent company of Salix Pharmaceuticals, which makes Xifaxan) has a patient support line that can sometimes help locate pharmacies with stock or connect you with their Patient Assistance Program. This is particularly useful if cost is also a barrier — see our cost-saving guide: How to Save Money on Rifaximin in 2026.
Some insurance plans offer mail-order pharmacy options that may have better access to specialty medications like Rifaximin. Your insurance company's member services line can tell you if this is available on your plan.
In addition to Medfinder, you can use our guide on checking pharmacy stock for additional tips on verifying availability before you make a trip.
You may see websites offering Rifaximin at lower prices from international pharmacies. Be extremely cautious. Medications purchased from unverified online sources may be counterfeit, improperly stored, or contain incorrect doses. Always fill your prescription through a licensed US pharmacy.
Finding Rifaximin in 2026 takes a little more planning than filling a typical prescription, but it's absolutely doable. Start with Medfinder to check real-time availability, expand your search to independent and specialty pharmacies, and plan your refills strategically. If you're still stuck, your doctor and the manufacturer's patient support team are there to help.
You shouldn't have to go without a medication you need. With the right tools and a proactive approach, you can stay ahead of supply issues and keep your treatment on track.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.